Tirzepatide is a synthetic 39-amino-acid peptide that acts as a dual agonist of the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors, making it one of the most-studied incretin-based research molecules. It is provided as a white lyophilized powder with a purity of not less than 99% by HPLC, packed in sealed vials to preserve activity. Investigators apply Tirzepatide in laboratory studies of appetite signaling, glucose homeostasis, insulin release and energy balance, as well as in receptor-binding and cell-signaling assays that probe combined GIP and GLP-1 pathways. The freeze-dried format ensures excellent stability and reproducible reconstitution with sterile water, supporting consistent dosing across repeated experiments. Every batch is quality-controlled, and a Certificate of Analysis is available for specific batches on request. For storage keep the sealed vial at 2-8 degree C protected from light, and for long-term storage keep at -20 degree C avoiding repeated freeze-thaw cycles. Small trial and bulk orders are both welcome, with OEM and neutral discreet packing available. For laboratory research use only, not for human or veterinary application.